Page 40 - CGIAR AR 2023 - Printable Med Res

Figure 2. CGIAR System revenue by source of funding, 2011–2023.

Figure 3 shows the main categories of expenditure. Overall, expenses in 2023 increased by 12% to
$859 million from $769 million in 2022. In 2023, 82% of expenditure was on research and
collaboration costs, and 18% was on general, administrative, and System-level costs.

Figure 3. Expenditure by main category, 2023 and 2022.

Figure 4 shows expenditure by CGIAR Science Groups/Action Areas by funding channel.

Resilient Agri-food Systems had the highest W1 spending at 36% followed by Genetic Innovation

with 34% and Systems Transformation with 32%.

Beginning from 2022, CGIAR dedicated Window 1 program funding entirely for Portfolio Initiatives
and Impact Area Platforms.

CGIAR Annual Report 2023 40